JAGSNPHARM Intraday Analysis...

JAGSNPHARM Share Price

Open 32.30 Change Price %
High 35.45 1 Day 1.70 5.25
Low 31.60 1 Week 1.95 6.07
Close 34.10 1 Month 2.90 9.29
Volume 156376 1 Year -2.95 -7.96
52 Week High 50.85
52 Week Low 25.80
JAGSNPHARM Important Levels
Resistance 2 37.67
Resistance 1 36.20
Pivot 33.72
Support 1 32.00
Support 2 30.53
NSE INDIA Most Active Stocks
JPASSOCIAT 18.55 5.10%
SOUTHBANK 31.45 8.26%
UNITECH 7.35 5.00%
IDEA 80.15 -3.67%
RCOM 19.75 -1.74%
ADANIPOWER 32.35 2.05%
DIVISLAB 942.80 9.22%
SUZLON 16.75 0.00%
HUDCO 89.45 1.36%
BOMDYEING 202.80 4.89%
More..
NSE INDIA Top Gainers Stocks
KSERASERA 0.15 50.00%
PANORAMUNI 9.60 20.00%
VIVIMEDLAB 138.20 19.97%
INDOTECH 256.60 19.24%
NAKODA 0.35 16.67%
ITDC 580.50 16.65%
HIRECT 143.25 15.57%
GSCLCEMENT 38.40 14.12%
DAMODARIND 109.80 13.96%
WALCHANNAG 231.50 13.96%
More..
NSE INDIA Top Losers Stocks
PRAKASHCON 4.55 -7.14%
PREMIERPOL 36.65 -6.51%
DQE 18.35 -6.38%
INTENTECH 87.35 -6.33%
PRATIBHA 10.00 -6.10%
SWANENERGY 148.25 -5.81%
TAKE 158.95 -5.72%
COMPUSOFT 14.10 -5.69%
SYNCOM 5.05 -5.61%
LITL 0.85 -5.56%
More..

Jagsonpal Pharmaceuticals Limited (NSE: JAGSNPHARM)

JAGSNPHARM Technical Analysis 1.5
As on 20th Sep 2017 JAGSNPHARM Share Price closed @ 34.10 and we RECOMMEND Sell for LONG-TERM with Stoploss of 37.51 & Buy for SHORT-TERM with Stoploss of 33.78 we also expect STOCK to react on Following IMPORTANT LEVELS.
JAGSNPHARM Target for September
1st Target up-side 36.85
2nd Target up-side 40.46
3rd Target up-side 44.07
1st Target down-side 26.55
2nd Target down-side 22.94
3rd Target down-side 19.33
Jagsonpal Pharmaceuticals Limited ( NSE INDIA Symbol : JAGSNPHARM )
Sector : Pharmaceuticals - Formulations And Other Stocks in Same Sector
JAGSNPHARM
34.10 1.70 (5.25 %)
LT : Sell
ST : Buy
AMRUTANJAN
616.05 5.10 (0.83 %)
LT : Buy
ST : Sell
JAGSNPHARM Synopsis Technicals View
50 Day EMA Close is Above EMA 50 (Short Term)
Bullish
100 Day EMA Close is Below EMA 100 (Mid Term) Bearish
200 Day EMA Close is Below EMA 200 (Long Term) Bearish
MACD (12 26 9) MACD Line is Grater Then SIGNAL Line Bullish
RSI (14) RSI is 58.05 Sideways
MFI (14) MFI is Above 80 Over Bought
CCI (20) CCI is Above 100 Over Bought
WILLIAM %R (14) William %R is -33.33 Sideways
ADX (14) ADX is 18.55 Range Bound
PSAR Stoploss For Long Buy 31.21
10 Day Avg Volume Traded 155.64 % More then 10 Day Average Volume
JAGSNPHARM Other Details
Segment EQ
Market Capital 0.00
Sector Pharmaceuticals - Formulations
Industry
Offical website
JAGSNPHARM Address
JAGSNPHARM
N/A
Interactive Technical Analysis Chart Jagsonpal Pharmaceuticals Limited ( JAGSNPHARM NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Jagsonpal Pharmaceuticals Limited
JAGSNPHARM Business Profile
Jagson Pharma is in the Pharmaceuticals - Formulations sector. Jagsonpal Pharmaceuticals (JAGSONPH) is a pharmaceutical company producing drugs and formulations. The company was incorporated in 1978 as a private limited company and went public in 1986. The company specializes in developing and manufacturing bulk drugs and pharmaceutical formulations. It focuses on several therapeutic groups like anti-arthritics, anti-inflammatories, analgesics, anti-spasmodics, progesterones, anabolic steroids, anesthetics and anti-fungals. Top selling brands include Lycored, Maintane, Metadec, Metabol, Doxypal DR, Parvon, and Indocap SR. The company manufactures active pharmaceutical ingredients (APIs) like Allylestrenol, Disulfiram, Tolnaftate, ..etc. The bulk drug range includes dextropropoxyphene HCl, tolnaftate, dextropropoxyphene napsylate and thiopental sodium. The manufacturing facility in Delhi is WHO and GMP-certified for the production of various dosage forms and bulk drugs and intermediates. The company also maintains a number of dedicated contract manufacturing facilities around the globe. It has an expanding international portfolio of affiliates, joint ventures and representative offices across the globe. The distribution network in India is comprised of over 1,500 authorized stockists who are serviced by depots. The products are retailed at over 125,000 pharmacies. The company is represented by 2,500 agents worldwide and has offices in three continents. The company`s operations span Russia, USA, Brazil, Ukraine, Sri Lanka, Cameroon, Argentina, Thailand, Germany, Switzerland, Korea, Egypt and Vietnam. The company has a sales office in New York through which it services North and Latin American clients and in Belarus, it has an operation center with a sales and distribution team. The current market capitalisation stands at Rs 23.71 crore.The company has reported a standalone sales of Rs 36.79 crore and a Net Profit of Rs 0.01 crore for the quarter ended Sep 2013. The company management includes R P S Kochhar - Chairman & Managing Director, S K Goyal - Director, Govind Deo - Additional Director, Bharat Sinh - Additional Director, Ishpal Singh Ghai - Additional Director. It is listed on the BSE with a BSE Code of 507789 and the NSE with an NSE Code of JAGSNPHARM. Its Registered office is at T-210 J, Shahpur Jat , New Delhi,Delhi - 110049.